Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 2, 2016
Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma in Non-surgical Candidates: Initial Clinical ExperienceJ H Chang, P Cheung, D Erler, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 16, 2017
Quantifying Health Utilities in Patients Undergoing Stereotactic Body Radiation Treatment for Liver Metastases for Use in Future Economic EvaluationsB Warren, P Munoz-Schuffenegger, K K W Chan, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 3, 2014
Predictive factors for local control in primary and metastatic lung tumours after four to five fraction stereotactic ablative body radiotherapy: a single institution's comprehensive experienceI Thibault, I Poon, L Yeung, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 29, 2021
Patient-reported Quality of Life following Stereotactic Body Radiation Therapy for Primary Kidney Cancer - Results from a Prospective Cohort StudyA Swaminath, P Cheung, R M Glicksman, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 2, 2015
Predictors of Chest Wall Toxicity after Lung Stereotactic Ablative RadiotherapyI Thibault, A Chiang, D Erler, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 10, 2022
Stereotactic Body Radiotherapy for Renal Cell Carcinoma: Oncological and Renal Function OutcomesR M Glicksman, P Cheung, R Korol, et al.
Clinical and Translational Radiation Oncology|March 4, 2022
Outcomes and toxicities in oligometastatic patients treated with stereotactic body radiotherapy for adrenal gland metastases: A multi-institutional retrospective studyA Baydoun, H Chen, I Poon, et al.
Pageof 1